JPRN-UMIN000036183已完成未知
Mechanism and efficacy of SGLT2 inhibitor in diabetes patients with renal anemia - SGLT2 inhibitor and renal anemia
ihon University Itabashi Hospital0 个研究点目标入组 9 人开始时间: 2019年3月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 9
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Intotelance for SGLT2 inhibitors 2. Past history of SGLT2 inhibitor before to 4 weeks at enrollment 3. Past history of administration of ESA before 12 weeks at enrollment 4. Ftn <50 ng/mL and TSAT <20% 5. HbA1c > 10.0% 6. Type 1 diabetes 7. eGFR<45mL/min/1.73m2 8. Pregnancy 9. alchol misuse 10. Severe ketosis, infection, and coma
研究者
相似试验
招募中
不适用
Effects of a SGLT2 Inhibitor in type 2 Diabetes Mellitustype 2 Diabetes MellitusJPRN-UMIN000017461ephrology, endocrinology and vascular medicine at Tohoku University Hospital60
招募中
2 期
SGLT2 lnhibition in Hemodialysis (DAPA-HD)Chronic Kidney Disease2024-518591-31-00Medical University Of Vienna220
招募中
不适用
Efficacy and safety in SGLT2 inhibitor for diabetes complicated by non-alcoholic fatty liver disease.Type 2 diabetes complicated by non-alcoholic fatty liver diseaseJPRN-UMIN000018166Toranomon Hospital, Department of Hepatology15
尚未招募
2 期
Mechanisms of action of SGLT2 inhibitors in patients with heart failure with reduced ejection fraction (HFrEF)Heart Failure with Reduced Ejection fractionCardiovascular - Other cardiovascular diseasesACTRN12621000187842The Alfred Hospital36
已完成
不适用
Effects of treatment with SGLT2 inhibitor on the initiation of continuous positive airway pressure therapy in type 2 diabetic patients with obstructive sleep apnea syndromeType 2 diabetesJPRN-UMIN000045226Akishima Clinic16